Sarcoma survivors needed for landmark study on life after cancer
NCT ID NCT06482957
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 36 times
Summary
This study is following 2,100 people of all ages who have had sarcoma, a rare type of cancer. Researchers want to learn how the disease and its treatments affect survivors over time, including side effects, lifestyle, and overall well-being. Participants will fill out surveys, provide blood, saliva, urine, stool, and tissue samples, and wear a FitBit to track activity. The goal is to identify factors that help or harm long-term health after sarcoma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University/Ingram Cancer Center
RECRUITINGNashville, Tennessee, 37203, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could reveal key factors that improve long-term outcomes and quality of life for sarcoma survivors.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may take years to influence care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.